Harwood Feffer LLP Announces Investigation of Synovis Life Technologies, Inc.
13 Dicembre 2011 - 11:50PM
Business Wire
Harwood Feffer LLP (www.hfesq.com)
is investigating potential claims against the board of directors of
Synovis Life Technologies, Inc. (“Synovis” or the “Company”)
(NASDAQ: SYNO) concerning the proposed acquisition of the Company
by Baxter International, Inc. (“Baxter”) in a transaction valued at
approximately $325 million.
On December 13, 2011, Synovis announced that it had entered into
a definitive merger agreement pursuant to which the Company will be
acquired by Baxter. Under the terms of the agreement, Synovis
shareholders will receive $28.00 per share in cash.
Our investigation concerns whether the board of directors is
fulfilling its fiduciary duties, maximizing the value of Synovis
and obtaining full and fair consideration for Synovis
stockholders.
If you own Synovis shares and wish to discuss this matter with
us, or have any questions concerning your rights and interests with
regard to this matter, please contact:
Robert I. Harwood, Esq. Benjamin Sachs-Michaels
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400 (212)935-7400
Email: bsachsmichaels@hfesq.com
Website: http://www.hfesq.com
Harwood Feffer has been representing individual and
institutional investors for many years, serving as lead counsel in
numerous cases in federal and state courts. Please visit the
Harwood Feffer LLP website (http://www.hfesq.com) for more
information about the firm.
Attorney Advertising. © 2011 Harwood Feffer LLP. The law firm
responsible for this advertisement is Harwood Feffer LLP
(www.hfesq.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter.
Grafico Azioni Synovis Life Technologies, Inc. (MM) (NASDAQ:SYNO)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Synovis Life Technologies, Inc. (MM) (NASDAQ:SYNO)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Synovis Life Technologies, Inc. (MM) (NASDAQ): 0 articoli recenti
Più Harwood Feffer LLP Articoli Notizie